PG
AVNS icon

PEAK6 Group’s Avanos Medical AVNS Stock Holding History

PEAK6 Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,900
Closed -$86K – 4079
2017
Q3 		$86K Buy
1,900
+900
+90% +$38.4K ﹤0.01% 3808
2017
Q2 		$39K Buy
+1,000
New +$37.8K ﹤0.01% 4183
2017
Q1 		– Sell
-700
Closed -$26K – 4278
2016
Q4 		$26K Sell
700
-5,000
-88% -$179K ﹤0.01% 4381
2016
Q3 		$198K Sell
5,700
-700
-11% -$24.5K ﹤0.01% 3153
2016
Q2 		$208K Buy
+6,400
New +$196K ﹤0.01% 3119
2015
Q3 		– Sell
-5,200
Closed -$211K – 5106
2015
Q2 		$211K Sell
5,200
-4,000
-43% -$180K ﹤0.01% 3665
2015
Q1 		$453K Buy
9,200
+6,200
+207% +$287K ﹤0.01% 2647
2014
Q4 		$136K Buy
+3,000
New +$118K ﹤0.01% 3642

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PEAK6 Group's AVNS Position: Q1 2017 in Review

PEAK6 Group sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 1,059 shares — an estimated $39K sold.

PEAK6 Group first reported a position in AVNS in Q2 2015 and held it in 3 quarters. The position peaked at $393K in Q2 2015. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • PEAK6 Group reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • PEAK6 Group sold 1,059 Avanos Medical shares in Q1 2017, an estimated $39K.
  • PEAK6 Group first reported a position in Avanos Medical in Q2 2015 and held it in 3 quarters.
  • PEAK6 Group's Avanos Medical position peaked at $393K in Q2 2015.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.